Cargando…

Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study

INTRODUCTION: Bicuspid aortic valve (BAV) patients have an increased risk to develop thoracic aortic complications. Little is known about the prevalence and severity of atherosclerosis in the BAV ascending aortic wall. This study evaluates and compares the prevalence of thoracic aortic atheroscleros...

Descripción completa

Detalles Bibliográficos
Autores principales: Dolmaci, Onur B., Klautz, Robert J. M., Poelmann, Robert E., Lindeman, Jan H. N., Sprengers, Ralf, Kroft, Lucia, Grewal, Nimrat
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355074/
https://www.ncbi.nlm.nih.gov/pubmed/37468858
http://dx.doi.org/10.1186/s12872-023-03396-4
_version_ 1785075063805968384
author Dolmaci, Onur B.
Klautz, Robert J. M.
Poelmann, Robert E.
Lindeman, Jan H. N.
Sprengers, Ralf
Kroft, Lucia
Grewal, Nimrat
author_facet Dolmaci, Onur B.
Klautz, Robert J. M.
Poelmann, Robert E.
Lindeman, Jan H. N.
Sprengers, Ralf
Kroft, Lucia
Grewal, Nimrat
author_sort Dolmaci, Onur B.
collection PubMed
description INTRODUCTION: Bicuspid aortic valve (BAV) patients have an increased risk to develop thoracic aortic complications. Little is known about the prevalence and severity of atherosclerosis in the BAV ascending aortic wall. This study evaluates and compares the prevalence of thoracic aortic atherosclerosis in BAV and tricuspid aortic valve (TAV) patients. METHODS: Atherosclerosis was objectified using three diagnostic modalities in two separate BAV patient cohorts (with and without an aortic dilatation). Within the first group, atherosclerosis was graded histopathologically according to the modified AHA classification scheme proposed by Virmani et al. In the second group, the calcific load of the ascending aorta and coronary arteries, coronary angiographies and cardiovascular risk factors were studied. Patients were selected from a surgical database (treated between 2006–2020), resulting in a total of 128 inclusions. RESULTS: Histopathology showed atherosclerotic lesions to be more prevalent and severe in all TAV as compared to all BAV patients (OR 1.49 (95%CI 1.14 – 1.94); p = 0.003). Computed tomography showed no significant differences in ascending aortic wall calcification between all BAV and all TAV patients, although a tendency of lower calcific load in favor of BAV was seen. Coronary calcification was higher in all TAV as compared to all BAV (OR 1.30 (95%CI 1.06 – 1.61); p = 0.014). CONCLUSION: Ascending aortic atherosclerotic plaques were histologically more pronounced in TAV as compared to the BAV patients, while CT scans revealed equal amounts of calcific depositions within the ascending aortic wall. This study confirms less atherosclerosis in the ascending aortic wall and coronary arteries of BAV patients as compared to TAV patients. These results were not affected by the presence of a thoracic aortic aneurysm. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-023-03396-4.
format Online
Article
Text
id pubmed-10355074
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103550742023-07-20 Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study Dolmaci, Onur B. Klautz, Robert J. M. Poelmann, Robert E. Lindeman, Jan H. N. Sprengers, Ralf Kroft, Lucia Grewal, Nimrat BMC Cardiovasc Disord Research INTRODUCTION: Bicuspid aortic valve (BAV) patients have an increased risk to develop thoracic aortic complications. Little is known about the prevalence and severity of atherosclerosis in the BAV ascending aortic wall. This study evaluates and compares the prevalence of thoracic aortic atherosclerosis in BAV and tricuspid aortic valve (TAV) patients. METHODS: Atherosclerosis was objectified using three diagnostic modalities in two separate BAV patient cohorts (with and without an aortic dilatation). Within the first group, atherosclerosis was graded histopathologically according to the modified AHA classification scheme proposed by Virmani et al. In the second group, the calcific load of the ascending aorta and coronary arteries, coronary angiographies and cardiovascular risk factors were studied. Patients were selected from a surgical database (treated between 2006–2020), resulting in a total of 128 inclusions. RESULTS: Histopathology showed atherosclerotic lesions to be more prevalent and severe in all TAV as compared to all BAV patients (OR 1.49 (95%CI 1.14 – 1.94); p = 0.003). Computed tomography showed no significant differences in ascending aortic wall calcification between all BAV and all TAV patients, although a tendency of lower calcific load in favor of BAV was seen. Coronary calcification was higher in all TAV as compared to all BAV (OR 1.30 (95%CI 1.06 – 1.61); p = 0.014). CONCLUSION: Ascending aortic atherosclerotic plaques were histologically more pronounced in TAV as compared to the BAV patients, while CT scans revealed equal amounts of calcific depositions within the ascending aortic wall. This study confirms less atherosclerosis in the ascending aortic wall and coronary arteries of BAV patients as compared to TAV patients. These results were not affected by the presence of a thoracic aortic aneurysm. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12872-023-03396-4. BioMed Central 2023-07-19 /pmc/articles/PMC10355074/ /pubmed/37468858 http://dx.doi.org/10.1186/s12872-023-03396-4 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Dolmaci, Onur B.
Klautz, Robert J. M.
Poelmann, Robert E.
Lindeman, Jan H. N.
Sprengers, Ralf
Kroft, Lucia
Grewal, Nimrat
Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
title Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
title_full Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
title_fullStr Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
title_full_unstemmed Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
title_short Thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
title_sort thoracic aortic atherosclerosis in patients with a bicuspid aortic valve; a case–control study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10355074/
https://www.ncbi.nlm.nih.gov/pubmed/37468858
http://dx.doi.org/10.1186/s12872-023-03396-4
work_keys_str_mv AT dolmacionurb thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy
AT klautzrobertjm thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy
AT poelmannroberte thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy
AT lindemanjanhn thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy
AT sprengersralf thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy
AT kroftlucia thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy
AT grewalnimrat thoracicaorticatherosclerosisinpatientswithabicuspidaorticvalveacasecontrolstudy